Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Proximal Risk for Suicide in Adolescents
Read the official source — NCT06400810Proximal Risk for Suicide in Adolescents
Effect of Progressive Resistance Training on insulin resistance and depression in adults with Metabolic Syndrome and Major Depressive Disorder.
PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
Read the official source — NCT07242586PS-Trauma: Udvikling af Traumebehandling Til Psykiatriske Patienter Med Psykoselidelse - et Pilotstudie.
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
Read the official source — NCT06898606Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including Brno-StredPsilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Read the official source — NCT06989957Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)
Psilocybin as a Novel Therapy for Residual Anhedonia
Read the official source — NCT07607938Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia
Psilocybin for Opioid Use Disorder (OUD)
Read the official source — NCT06796062A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Read the official source — NCT04123314Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
Read the official source — NCT06378229Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus
Psilocybin for Methamphetamine Addiction
Read the official source — NCT06899594A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine
Psilocybin for Prolonged Grief Disorder
Read the official source — NCT06724289We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.